Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
67.105,89
0,25%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Catabasis Pharmaceuticals Inc (CATB) Catabasis Pharmaceuticals Inc (CATB) Notizie

CATB

Catabasis Pharmaceuticals (CATB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CATB
DataOraFonteTitoloSimboloCompagnia
06/06/202314:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
24/05/202312:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CATBCatabasis Pharmaceuticals Inc
11/05/202322:11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CATBCatabasis Pharmaceuticals Inc
20/04/202322:05Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CATBCatabasis Pharmaceuticals Inc
20/04/202322:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
19/04/202314:09Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CATBCatabasis Pharmaceuticals Inc
06/04/202322:01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
31/03/202314:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
14/02/202321:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
10/01/202318:49Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CATBCatabasis Pharmaceuticals Inc
21/12/202222:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
15/12/202223:17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CATBCatabasis Pharmaceuticals Inc
21/06/202214:34Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
13/05/202212:08Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CATBCatabasis Pharmaceuticals Inc
27/04/202214:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
10/03/202222:46Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
10/02/202222:10Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:CATBCatabasis Pharmaceuticals Inc
08/09/202114:00Business WireCatabasis Pharmaceuticals Announces New Company Name, Astria Therapeutics, Highlighting New Company FocusNASDAQ:CATBCatabasis Pharmaceuticals Inc
09/08/202122:10Business WireCatabasis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides a Corporate UpdateNASDAQ:CATBCatabasis Pharmaceuticals Inc
04/08/202114:00Business WireCatabasis Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare ConferenceNASDAQ:CATBCatabasis Pharmaceuticals Inc
07/07/202114:00Business WireCatabasis Pharmaceuticals To Present At Ladenburg Thalmann 2021 Healthcare ConferenceNASDAQ:CATBCatabasis Pharmaceuticals Inc
17/06/202119:42Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CATBCatabasis Pharmaceuticals Inc
10/06/202122:06Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
14/05/202114:00Business WireCatabasis Pharmaceuticals To Present At Upcoming Investor ConferencesNASDAQ:CATBCatabasis Pharmaceuticals Inc
13/05/202122:10Business Wire Catabasis Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides a Corporate UpdateNASDAQ:CATBCatabasis Pharmaceuticals Inc
11/03/202122:35Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CATBCatabasis Pharmaceuticals Inc
11/03/202122:10Business WireCatabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate UpdateNASDAQ:CATBCatabasis Pharmaceuticals Inc
02/03/202114:00Business WireCatabasis Pharmaceuticals To Present At Upcoming Investor Conferences   NASDAQ:CATBCatabasis Pharmaceuticals Inc
08/02/202122:52Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:CATBCatabasis Pharmaceuticals Inc
29/01/202114:00Business WireCatabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.NASDAQ:CATBCatabasis Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CATB

La tua Cronologia

TSX
IXTE
Invesco S&P TSX 60 ESG T...
BIT
F37564
Vontobel Financial Produ...
NYSE
BMI
Badger Meter
BIT
F16109
Vontobel Financial Produ...
NYSE
MITN
AG Mortgage Investment
USOTC
INPOY
InPost (PK)
UNSW3
GRMTKETH
Gramatik
GATE
BUYUSDT
Wrapped BUY Token
TSXV
PLX.WT
Point Loma Resources
NASDAQ
GIIXU
Gores Holdings VIII
NASDAQ
FTCUX
Franklin Corefolio 529 P...
LSE
XMID
Xindonesiasw 1c
USOTC
HLRD
Hilliard (CE)
HUOB
ZILETH
Zilliqa
COIN
CADXXGBP
LSE
EF90
Citi Fun 25
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network